Furosemide Tablets
Awarded Award Notice Posted
- Solicitation number
- SPE2D221R0110
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Awarded
- to Avkare LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D222D0140 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Charlotte, North Carolina 28206, United States
- Points of contact
-
- Kyle Lewicki kyle.lewicki@dla.mil (445) 737-0977
- Jason Wray jason.wray@dla.mil (445) 737-6304
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-22-D-0140 to AvKARE, LLC on December 8, 2021, for the supply of Furosemide Tablets with an initial contract value of $16,701,923.95. The contract includes multiple option years, with Option Year 1 invoked in November 2022, Option Year 2 exercised effective December 8, 2023 through December 7, 2024, Option Year 3 extended through December 7, 2025, and Option Year 4 exercised for the period December 8, 2025 through December 7, 2026. Throughout the contract's performance period, the government has issued several modifications to incorporate compliance requirements including Drug Supply Chain Act language, ByteDance prohibition clauses, Federal Acquisition Supply Chain Security Act orders, and adjustments related to recent Executive Orders. This contract represents a multi-year pharmaceutical supply arrangement supporting Department of Defense medical supply chain requirements.
Notice text
6 versions
Update #6 · Latest ·
SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Update #5 ·
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Update #4 ·
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Update #3 ·
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Update #2 ·
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Update #1 ·
Contract Award for Furosemide Tablets SPE2D222D0140
Awarded contract SPE2D222D0140 to AvKARE, LLC for 16701923.95 on 2021-12-08.
Attachments
| File | Type | Posted |
|---|---|---|
| Modification P00007 SPE2D222D0140.PDF | ||
| Modification P00008 SPE2D222D0140 Option Year 4.PDF | ||
| Option Year 3 Modification P00006 SPE2D222D0140.PDF | ||
| Modification P00005 SPE2D222D0140.PDF | ||
| Option Year 2 Modification P00004 SPE2D2-22-D-0140.pdf | ||
| Signed SPE2D222D0140 P00003 Furosemide.pdf | ||
| SF30_SPE2D222D0140P00002.PDF | ||
| Option Year 1 Modification P00001 SPE2D2-22-D-0140.PDF | ||
| Signed Furosemide SPE2D222D0140.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Furosemide Tablets | Award Notice | |
| Manufacture/Distributor Br-Philadelp | Award Notice | |
| Furosemide Tablets | Solicitation | |
| Furosemide Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity